|Articles|March 1, 2002
ALA / PDT therapy branches toward benign skin tumors
New Orleans - With a brief yet successful track record of treatingmalignant and pre-malignant skin conditions, 5-aminolevulinic acid (ALA)in combination with photodynamic therapy (PDT) could soon become an effectivealternative for benign cutaneous tumors such as sebaceous hyperplasia, seborrheickeratoses, and plantar warts.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Highlighting Major Breakthroughs for Atopic Dermatitis and Psoriasis in 2025
2
First-in-Class Topical GT20029 Demonstrates Promising Phase 2 Efficacy and Tolerability for AGA
3
Balancing Pathophysiology and Patient Lifestyle in Acne Management: Part 2
4
Topicals Demonstrate Targeted Control Across 3 Distinct Atopic Dermatitis Cases
5













